Safety and Tolerability Established Good and Excellent Functional Outcome Increased YONGIN, South Korea–(BUSINESS WIRE)–GNT Pharma Inc. today reports positive top-line results from a phase II, double-blind, randomized, placebo-controlled, multi-center study assessing the safety and efficacy of nelonemdaz in acute ischemic stroke patients treated with endovascular thrombectomy within 8 hours of symptom […]
Other News
Endologix Launches ALTO™ Abdominal Stent Graft System in Europe
First European Commercial Case Completed at East & North Hertfordshire Hospital in England IRVINE, Calif.–(BUSINESS WIRE)—Oct 15, 2020–Furthering its mission to transform the treatment of aortic disorders, Endologix LLC today announced the first implant of its ALTO™ Abdominal Stent Graft, commencing the European commercial release of the recently CE Mark […]
Bluegrass Vascular Announces Publication of Surfacer System SAVE Registry Results
San Antonio, TX – Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results from the company’s prospective, multicenter SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry in the Journal of Vascular and Interventional Radiology (JVIR). […]
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut™ TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN, Oct. 14, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic […]
Late-breaking trial published in BMJ proves the efficacy of Coala Heart Monitor as part of cryptogenic stroke management
Non-invasive Coala Heart Monitor validated in real-world cryptogenic stroke patients as the main evaluation tool to help detect Atrial Fibrillation and prevent additional strokes. IRVINE, Calif., Oct. 14, 2020 /PRNewswire/ — Coala Life, a Swedish innovator in remote cardiac and respiratory monitoring, today announced the results of a late-breaking trial on cryptogenic stroke […]
VivaLNK Partners with AMPS, Increasing Accuracy and Reliability for Continuous ECG and Vitals Monitoring
ECG data gathered through VivaLNK and AMPS’ technologies advancing clinical trial and remote patient monitoring efficiency CAMPBELL, Calif., Oct. 14, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, and AMPS, the world leader in the production of software tools for electrocardiogram (ECG), have partnered to advance Remote Patient Monitoring (RPM) for […]
Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
CALGARY, Oct. 14, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that Vision Leader Limited, a wholly-owned subsidiary of ORI Star Fund LP (“ORI”), has delivered a notice of conversion to convert its entire September 2019 debenture and associated interest, into Resverlogix common shares, which […]
Merit Medical Systems Finalizes Resolution with the Government
SOUTH JORDAN, Utah, Oct. 13, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has finalized its settlement with the […]
Results of the PROSPECT II Natural History Study Demonstrate High-Risk Plaques Identified by NIRS+IVUS Imaging are Linked to Future Coronary Events
PROSPECT ABSORB, a randomized substudy, showed treatment of high risk plaques with BVS is safe and associated with favorable long-term clinical outcomes compared to GDMT alone BEDFORD, Mass.–(BUSINESS WIRE)–Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced positive results from the PROSPECT II and […]
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology
Half Moon Medical’s Technology Now Ready for Evaluation in Early Feasibility Study DUBLIN, Oct. 14, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a partnership with The Foundry – a medical device company incubator – dating back to mid-2017 to invest in and create a company with the […]



